Elixinol Wellness will acquire personalised supplement platform Vitable for headline consideration of A$2.5 million in shares, adding recurring revenue and more than 7,850 active subscribers. The deal could lift combined revenue to A$27 million by 2028, but remains subject to shareholder approval and carries meaningful dilution risk.
